# Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012

> **NCT01344057** · PHASE2 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 63 (actual)

## Conditions studied

- Seasonal Influenza

## Interventions

- **BIOLOGICAL:** Seasonal Influenza Vaccine

## Key facts

- **NCT ID:** NCT01344057
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2023-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01344057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01344057, "Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01344057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*